Eng Jason W-L, Kokolus Kathleen M, Reed Chelsey B, Hylander Bonnie L, Ma Wen W, Repasky Elizabeth A
Department of Immunology, Roswell Park Cancer Institute, Elm and Carlton Streets, Buffalo, NY, 14263, USA.
Cancer Immunol Immunother. 2014 Nov;63(11):1115-28. doi: 10.1007/s00262-014-1617-9. Epub 2014 Oct 12.
Long conserved mechanisms maintain homeostasis in living creatures in response to a variety of stresses. However, continuous exposure to stress can result in unabated production of stress hormones, especially catecholamines, which can have detrimental health effects. While the long-term effects of chronic stress have well-known physiological consequences, recent discoveries have revealed that stress may affect therapeutic efficacy in cancer. Growing epidemiological evidence reveals strong correlations between progression-free and long-term survival and β-blocker usage in cancer patients. In this review, we summarize the current understanding of how the catecholamines, epinephrine and norepinephrine, affect cancer cell survival and tumor progression. We also highlight new data exploring the potential contributions of stress to immunosuppression in the tumor microenvironment and the implications of these findings for the efficacy of immunotherapies.
长期保守的机制可维持生物体内的稳态以应对各种应激。然而,持续暴露于应激状态会导致应激激素,尤其是儿茶酚胺的持续产生,这可能对健康产生有害影响。虽然慢性应激的长期影响具有众所周知的生理后果,但最近的发现表明,应激可能会影响癌症的治疗效果。越来越多的流行病学证据表明,癌症患者的无进展生存期和长期生存率与使用β受体阻滞剂之间存在密切关联。在本综述中,我们总结了目前对儿茶酚胺、肾上腺素和去甲肾上腺素如何影响癌细胞存活和肿瘤进展的理解。我们还强调了新的数据,这些数据探索了应激对肿瘤微环境中免疫抑制的潜在影响以及这些发现对免疫疗法疗效的意义。